182 related articles for article (PubMed ID: 14660719)
1. Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics.
Strauss LG; Dimitrakopoulou-Strauss A; Haberkorn U
J Nucl Med; 2003 Dec; 44(12):1933-9. PubMed ID: 14660719
[TBL] [Abstract][Full Text] [Related]
2. Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach.
Sundaram SK; Freedman NM; Carrasquillo JA; Carson JM; Whatley M; Libutti SK; Sellers D; Bacharach SL
J Nucl Med; 2004 Aug; 45(8):1328-33. PubMed ID: 15299057
[TBL] [Abstract][Full Text] [Related]
3. Searching for alternatives to full kinetic analysis in 18F-FDG PET: an extension of the simplified kinetic analysis method.
Hapdey S; Buvat I; Carson JM; Carrasquillo JA; Whatley M; Bacharach SL
J Nucl Med; 2011 Apr; 52(4):634-41. PubMed ID: 21421718
[TBL] [Abstract][Full Text] [Related]
4. Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy.
Dimitrakopoulou-Strauss A; Strauss LG; Burger C; Rühl A; Irngartinger G; Stremmel W; Rudi J
J Nucl Med; 2004 Sep; 45(9):1480-7. PubMed ID: 15347714
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG kinetics and gene expression in giant cell tumors.
Strauss LG; Dimitrakopoulou-Strauss A; Koczan D; Bernd L; Haberkorn U; Ewerbeck V; Thiesen HJ
J Nucl Med; 2004 Sep; 45(9):1528-35. PubMed ID: 15347720
[TBL] [Abstract][Full Text] [Related]
6. Comparison of methods to quantitate 18F-FDG uptake with PET during experimental acute lung injury.
Chen DL; Mintun MA; Schuster DP
J Nucl Med; 2004 Sep; 45(9):1583-90. PubMed ID: 15347728
[TBL] [Abstract][Full Text] [Related]
7. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
Trägårdh M; Møller N; Sørensen M
J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
[TBL] [Abstract][Full Text] [Related]
8. Shortened acquisition protocols for the quantitative assessment of the 2-tissue-compartment model using dynamic PET/CT 18F-FDG studies.
Strauss LG; Pan L; Cheng C; Haberkorn U; Dimitrakopoulou-Strauss A
J Nucl Med; 2011 Mar; 52(3):379-85. PubMed ID: 21321263
[TBL] [Abstract][Full Text] [Related]
9. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.
Kurland BF; Muzi M; Peterson LM; Doot RK; Wangerin KA; Mankoff DA; Linden HM; Kinahan PE
J Nucl Med; 2016 Feb; 57(2):226-30. PubMed ID: 26493206
[TBL] [Abstract][Full Text] [Related]
10. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
[TBL] [Abstract][Full Text] [Related]
11. Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study.
Akamatsu G; Ikari Y; Nishida H; Nishio T; Ohnishi A; Maebatake A; Sasaki M; Senda M
J Nucl Med Technol; 2015 Sep; 43(3):222-6. PubMed ID: 26271802
[TBL] [Abstract][Full Text] [Related]
12. (18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy.
Guo J; Guo N; Lang L; Kiesewetter DO; Xie Q; Li Q; Eden HS; Niu G; Chen X
J Nucl Med; 2014 Jan; 55(1):154-60. PubMed ID: 24232871
[TBL] [Abstract][Full Text] [Related]
13. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
[TBL] [Abstract][Full Text] [Related]
14. Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis.
Røe K; Aleksandersen TB; Kristian A; Nilsen LB; Seierstad T; Qu H; Ree AH; Olsen DR; Malinen E
Acta Oncol; 2010 Oct; 49(7):914-21. PubMed ID: 20831478
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
16. The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions.
Dimitrakopoulou-Strauss A; Strauss LG; Heichel T; Wu H; Burger C; Bernd L; Ewerbeck V
J Nucl Med; 2002 Apr; 43(4):510-8. PubMed ID: 11937595
[TBL] [Abstract][Full Text] [Related]
17. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.
Dimitrakopoulou-Strauss A; Strauss LG; Schwarzbach M; Burger C; Heichel T; Willeke F; Mechtersheimer G; Lehnert T
J Nucl Med; 2001 May; 42(5):713-20. PubMed ID: 11337565
[TBL] [Abstract][Full Text] [Related]
18. SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.
Beaulieu S; Kinahan P; Tseng J; Dunnwald LK; Schubert EK; Pham P; Lewellen B; Mankoff DA
J Nucl Med; 2003 Jul; 44(7):1044-50. PubMed ID: 12843218
[TBL] [Abstract][Full Text] [Related]
19. Short dynamic FDG-PET imaging protocol for patients with lung cancer.
Torizuka T; Nobezawa S; Momiki S; Kasamatsu N; Kanno T; Yoshikawa E; Futatsubashi M; Okada H; Ouchi Y
Eur J Nucl Med; 2000 Oct; 27(10):1538-42. PubMed ID: 11083544
[TBL] [Abstract][Full Text] [Related]
20. "Population" approach improves parameter estimation of kinetic models from dynamic PET data.
Bertoldo A; Sparacino G; Cobelli C
IEEE Trans Med Imaging; 2004 Mar; 23(3):297-306. PubMed ID: 15027522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
